文献速递湿疹皮炎与荨麻疹

中重度特应性皮炎系统治疗患者不同护肤方案的随机对照试验比较

Comparison of different skin care regimens in patients with moderate to severe atopic dermatitis receiving systemic treatment: A randomized controlled trial.
PubMed 文献 · J Eur Acad Dermatol Venereol · 2023-04-24

这项随机对照多中心研究纳入57例中重度特应性皮炎(AD)患者,比较在系统治疗基础上使用「加强型润肤剂」方案与常规润肤剂/清洁剂的疗效。10周后,「加强型润肤剂」组当前瘙痒改善显著更优,部分DLQI条目改善更明显,且产品用量较对照组少23%。

要点

  • 中重度AD系统治疗基础上,「加强型润肤剂」方案10周时瘙痒改善显著优于常规护肤。
  • 「加强型润肤剂」组部分DLQI条目改善更明显,产品用量较对照组少23%。
  • 研究强调AD患者每日使用润肤剂的重要性,尤其「加强型润肤剂」有助改善体征、症状和生活质量。

核心结论

  • 在中重度AD接受系统治疗的患者中,「加强型润肤剂」方案较对照组显著改善瘙痒和生活质量条目,10周内产品用量少23%。

研究设计与样本

  • 随机对照多中心研究,纳入57例中重度AD(SCORAD评分≥40)且接受系统治疗(环孢素A、度普利尤单抗或Janus激酶抑制剂)的患者,1:1随机分组。

主要发现

  • 患者平均年龄38岁(范围19-70岁)。
  • 10周后平均润肤剂用量:「加强型润肤剂」组447.3 g(范围29-1099 g)vs 对照组613.2 g(范围97-2565 g),p=0.0277。
  • 10周后「加强型润肤剂」组当前瘙痒较对照组显著改善(p=0.0277),部分DLQI条目改善更明显。

关键数值与推荐

  • 「加强型润肤剂」方案为每日两次使用「加强型润肤剂」软膏,先用配套合成清洁剂预清洁,持续10周。
  • 对照组继续使用其常规润肤剂和清洁剂。

临床怎么用

  • 原文结论强调AD患者每日使用润肤剂的重要性,尤其「加强型润肤剂」有助改善体征、症状和生活质量。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Moderate to severe AD can be successfully managed by systemic treatments. Current guidelines also recommend emollients or emollients 'plus' and eudermic cleansers for all AD patients to improve the skin barrier and provide anti-irritant and anti-pruritic effects. OBJECTIVES: To investigate the efficacy of skin care (in addition to systemic treatment) with an Emollient 'plus' balm designed to improve the skin barrier and skin microbiome plus a corresponding syndet compared to usual commercial emollients and cleansers. METHODS: In a randomized controlled multicenter study, patients with moderate to severe AD (Severity scoring of atopic dermatitis [SCORAD] score ≥ 40) receiving systemic treatment (cyclosporin A, dupilumab or a Janus kinase inhibitor) were randomized 1:1 to apply twice daily for 10 weeks Emollient 'plus' after pre-cleaning with the syndet (Emollient 'plus' group) or to continue with their usual emollient and cleanser (Control group). Assessments included SCORAD, pruritus on a Visual Analog Scale, Dermatology quality of life questionnaire (DLQI), efficacy and tolerance questionnaires. RESULTS: Included were 57 patients with mean age of 38 years (range 19-70 years). The mean amount of emollient used after 10 weeks was 447.3 g (range 29-1099 g) and 613.2 g (range 97-2565 g) for the Emollient 'plus' versus the Control, respectively (p = 0.0277). After 10 weeks, subjects in the Emollient 'plus' had a significantly greater reduction in current pruritus (p = 0.0277) and a greater reduction in some DLQI items compared to the Control group. CONCLUSIONS: In patients with moderate to severe AD receiving systemic treatment, the Emollient 'plus' regimen significantly improved pruritus and quality of life items compared to the control, while using 23% less product over a 10-week period. These results stress the importance of daily use of emollients, especially emollients 'plus' to improve signs, symptoms and quality of life in patients with AD.

来源:J Eur Acad Dermatol Venereol,查看原文。版权归原作者所有。

引用

  1. Magnolo N, Jaenicke T, Tsianakas A, et al. Comparison of different skin care regimens in patients with moderate to severe atopic dermatitis receiving systemic treatment: A randomized controlled trial. J Eur Acad Dermatol Venereol. 2023. PMID: 37092275. doi:10.1111/jdv.18949

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。